This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Kforce (KFRC) Lags Q2 Earnings Estimates
by Zacks Equity Research
Kforce (KFRC) delivered earnings and revenue surprises of -1.67% and +0.16%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
Analysts Estimate Cross Country Healthcare (CCRN) to Report a Decline in Earnings: What to Look Out for
by Zacks Equity Research
Cross Country (CCRN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Cross Country Healthcare (CCRN) Q1 Earnings Top Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 50% and 3.67%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Are Investors Undervaluing Cross Country Healthcare (CCRN) Right Now?
by Zacks Equity Research
Here at Zacks, our focus is on the proven Zacks Rank system, which emphasizes earnings estimates and estimate revisions to find great stocks. Nevertheless, we are always paying attention to the latest value, growth, and momentum trends to underscore strong picks.
Cross Country (CCRN) Q4 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
The headline numbers for Cross Country (CCRN) give insight into how the company performed in the quarter ended December 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Cross Country Healthcare (CCRN) Misses Q4 Earnings Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of -63.64% and 1.22%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
5 Broker-Loved Stocks to Keep an Eye on Amid Trade Tensions
by Maharathi Basu
Investors should monitor stocks like Cardinal Health, DXC Technology, Cross Country Healthcare, Avnet and Asbury for high returns.
Zacks Industry Outlook Highlights HireQuest, Heidrick & Struggles and Cross Country Healthcare
by Zacks Equity Research
HireQuest, Heidrick & Struggles and Cross Country Healthcare have been highlighted in this Industry Outlook article.
3 Staffing Stocks to Consider Despite Industry Challenges
by Zacks Equity Research
The Zacks Staffing Firms industry is hindered by the manufacturing sector's economic downturn. However, HSII, CCRN and HQI are likely to be the leading entities to witness steady service demand, and the rising adoption of remote work and technology.
Insperity, Inc. (NSP) Q4 Earnings and Revenues Top Estimates
by Zacks Equity Research
Insperity (NSP) delivered earnings and revenue surprises of 150% and 0.97%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?
Cross Country (CCRN) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates
by Zacks Equity Research
The headline numbers for Cross Country (CCRN) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Cross Country Healthcare (CCRN) Surpasses Q3 Earnings and Revenue Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of 20% and 1.63%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
TrueBlue (TBI) Reports Q3 Loss, Misses Revenue Estimates
by Zacks Equity Research
TrueBlue (TBI) delivered earnings and revenue surprises of 52.17% and 0.19%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Is the Options Market Predicting a Spike in Cross Country Healthcare (CCRN) Stock?
by Zacks Equity Research
Investors need to pay close attention to Cross Country Healthcare (CCRN) stock based on the movements in the options market lately.
Cross Country (CCRN) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
While the top- and bottom-line numbers for Cross Country (CCRN) give a sense of how the business performed in the quarter ended June 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Cross Country Healthcare (CCRN) Lags Q2 Earnings Estimates
by Zacks Equity Research
Cross Country (CCRN) delivered earnings and revenue surprises of -28.57% and 1.63%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Do Options Traders Know Something About Cross Country Healthcare (CCRN) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Cross Country Healthcare (CCRN) stock based on the movements in the options market lately.
Compared to Estimates, Cross Country (CCRN) Q1 Earnings: A Look at Key Metrics
by Zacks Equity Research
While the top- and bottom-line numbers for Cross Country (CCRN) give a sense of how the business performed in the quarter ended March 2024, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
New Strong Sell Stocks for February 27th
by Zacks Equity Research
CAR, CCRN and ECPG have been added to the Zacks Rank #5 (Strong Sell) List on February 27, 2023.
5 Stocks Favored by Brokers Amid the Current Uncertainty
by Maharathi Basu
We believe that stocks like Deutsche Bank (DB), Cross Country Healthcare (CCRN), Bread Financial (BFH), American Axle (AXL) and Cardinal Health (CAH) should be on an investor's watchlist.
Cross Country (CCRN) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for Cross Country (CCRN) give insight into how the company performed in the quarter ended December 2023, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Curious about Cross Country (CCRN) Q4 Performance? Explore Wall Street Estimates for Key Metrics
by Zacks Equity Research
Besides Wall Street's top -and-bottom-line estimates for Cross Country (CCRN), review projections for some of its key metrics to gain a deeper understanding of how the company might have fared during the quarter ended December 2023.
The Zacks Analyst Blog Highlights Cross Country Healthcare, HireQuest, Heidrick & Struggles, KornFerry and TrueBlue
by Zacks Equity Research
Cross Country Healthcare, HireQuest, Heidrick & Struggles, KornFerry and TrueBlue are included in this Analyst Blog.
5 Staffing Stocks to Gain as Labor Market Remains Hot
by Tirthankar Chakraborty
Keep an eye on staffing stocks like Cross Country Healthcare (CCRN), HireQuest (HQI), Heidrick & Struggles International (HSII), KornFerry International (KFY) and TrueBlue (TBI), banking on solid January jobs growth.
Compared to Estimates, Cross Country (CCRN) Q3 Earnings: A Look at Key Metrics
by Zacks Equity Research
Although the revenue and EPS for Cross Country (CCRN) give a sense of how its business performed in the quarter ended September 2023, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.